Back to News

Call for Member Applications: HIV Cure and Immunotherapy Scientific Committee

ShareShare

The IMPAACT Scientific Leadership Group (SLG) in collaboration with the Chair and Vice Chair of the IMPAACT HIV Cure and Immunotherapy Scientific Committee (SC) are soliciting members to expand and revise research priorities and align expertise within each of the key research areas of the Network. 

The IMPAACT HIV Cure and Immunotherapy SC is seeking additional members with expertise in HIV virology and immunology, HIV reservoirs, innovative immunotherapies, and non-HIV vaccines and immunotherapies for pathogens that are high priority for infants, children, and adolescents as well as pregnant and postpartum people who are impacted by or living with HIV. 

The scientific aim of the HIV Cure and Immunotherapy SC is to evaluate the potential for ART-free HIV remission through therapeutic interventions aimed at prevention, clearance and post-treatment control of HIV reservoirs in infants, children and adolescents with HIV and leverage expertise for evaluation of vaccines for HIV and related/cooccurring conditions among infants, children, and adolescents, as well as among pregnant and postpartum people. Learn more about the current portfolio and prior research from the HIV Cure and Immunotherapy Scientific Committee. 

The Cure and Immunotherapy SC is seeking additional members.
The Cure and Immunotherapy SC is seeking additional members.

Apply Now

If you would like to be considered for this solicitation, please send your CV or NIH biographical sketch, a personal statement of why you would like to serve on the HIV Cure and Immunology SC, and a brief description (1-2 pages) of your relevant expertise and experience. The application should be submitted by email to IMPAACTops@fhi360.org by Monday, 18 November 2024.